Clinical Features and Treatment Outcomes of Intravascular Large B-Cell Lymphoma: A Single-Center Experience in Korea
Authors:
- Hee Jin KimHKHee Jin Kim
- Young Hyeh KoYKYoung Hyeh Ko
- Joon Young ChoiJCJoon Young Choi
- Chul Won JungCJChul Won Jung
- Seok Jin KimSKSeok Jin Kim
- Won Seog KimWKWon Seog Kim
- 10 September 2013
- journal article
- research article
- Published by S. Karger AG in Acta Haematologica
- Vol. 131 (1) , 18-27
Abstract
Background: Clinical features and treatment outcomes of intravascular large B-cell lymphoma (IVLBCL) have rarely been reviewed due to its rarity and pathologic obscurity. Methods: We analyzed 20 patients who were pathologically diagnosed with IVLBCL at the Samsung Medical Center. Results: Initial manifestations were nonspecific, such as fever with cytopenia, elevated serum lactate dehydrogenase and hypoalbuminemia. Hemophagocytosis was frequent and bone marrow was the most common site of pathologic diagnosis in our series. Hepatosplenomegaly, pleural effusion and ground-glass opacity in the lungs were also commonly found, and positron emission tomography imaging showed increased 18F-fluorodeoxyglucose uptake in the involved organs. All patients received CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) or rituximab-CHOP. The median overall survival (OS) was 38.9 months (95% confidence interval 6.7-71.1). Rituximab-containing chemotherapy compared to chemotherapy alone resulted in higher 3-year OS (71.4 and 25.0%; p = 0.027). Patients with hemophagocytosis had a poorer 3-year OS compared to patients without hemophagocytosis (29.6 and 75%; p = 0.046). Prognostic factor analysis showed the association of pleural effusion with worse OS (p = 0.002). Conclusions: Treatment with rituximab-containing chemotherapy can improve the treatment outcome of IVLBCL. Pleural effusion may be a poor prognostic factor in patients with IVLBCL.Keywords
This publication has 34 references indexed in Scilit:
- Silent Intravascular Lymphoma Initially Manifesting as a Unilateral Adrenal IncidentalomaCase Reports in Medicine, 2012
- Primary Intravascular large B-cell lymphoma of lung: a report of one case and reviewDiagnostic Pathology, 2012
- Insufficiency of Positron Emission Tomography and Magnetic Resonance Spectroscopy in the Diagnosis of Intravascular Lymphoma of the Central Nervous SystemCase Reports in Oncology, 2012
- High frequency of neurolymphomatosis as a relapse disease of intravascular large B‐cell lymphomaCancer, 2011
- Retrospective Analysis of Intravascular Large B-Cell Lymphoma Treated With Rituximab-Containing Chemotherapy As Reported by the IVL Study Group in JapanJournal of Clinical Oncology, 2008
- Use of Random Skin Biopsy for Diagnosis of Intravascular Large B-Cell LymphomaMayo Clinic Proceedings, 2007
- Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus MeetingJournal of Clinical Oncology, 2007
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007
- Adrenal enlargement and insufficiency: A common presentation of intravascular large B-cell lymphomaAmerican Journal of Hematology, 2006
- Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’1British Journal of Haematology, 2004